FRANKLIN LAKES, N.J., Sept. 30, 2020 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced its rapid, point-of-care, SARS-CoV-2 ...
Becton, Dickinson and Company BDX, popularly known as BD, recently announced receipt of the FDA’s Emergency Use Authorization (“EUA”) for the BD Veritor At-Home COVID-19 Test. The test is an ...
- Simple new assay leverages more than 25,000 BD Veritor™ instruments already used across the U.S. to immediately increase access to COVID-19 testing in frontline health care settings - BD will begin ...
New CLIA-Waived Test Delivers Digital Results to Support Timely Clinical Decision-Making FRANKLIN LAKES, N.J., July 30, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company (BDX)), a leading global ...
BD's new hand-held test runs on the Veritor system, with a device about the size of a cellphone, using nasal swabs. BD says the platform has already been used at more than 25,000 U.S. locations to ...
Becton, Dickinson and Co. (BD) completed its acquisition of Scanwell Health Inc., its partner in development of the smartphone-enabled BD Veritor At-Home COVID-19 Test, just in time for increased ...
FRANKLIN LAKES, N.J. – USA Track & Field (USATF) and BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, have partnered to provide rapid COVID-19 testing for ...
BD (Becton, Dickinson and Company), a leading global medical technology company, today announced the launch of its next generation wireless rapid diagnostic system for detection of influenza A and B, ...
FRANKLIN LAKES, NJ and INDIANAPOLIS (Feb. 25, 2022) — USA Track & Field and BD, a leading global medical technology company, today announced the extension of BD’s sponsorship through 2022. As the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results